PTP1B inhibitors

PTP1B inhibitors has been studied in 1 paper since 2023: none in people yet, 1 review. No study of it in people or animals has been published yet. The newest paper, Jun 14, 2023: “Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease”.